Document is current
Any future updates will be listed below
-
Authors
Almási, Éva d. H. https://orcid.org/0000-0001-5042-5478
Eisenhard, Lea
Osbelt, Lisa https://orcid.org/0000-0002-4862-650X
Lesker, Till Robin
Vetter, Anna C. https://orcid.org/0000-0001-7471-2447
Knischewski, Nele
Bielecka, Agata Anna
Gronow, Achim
Muthukumarasamy, Uthayakumar
Wende, Marie
Tawk, Caroline
Neumann-Schaal, Meina https://orcid.org/0000-0002-1641-019X
Brönstrup, Mark https://orcid.org/0000-0002-8971-7045
Strowig, Till https://orcid.org/0000-0003-0185-1459
-
Funding
Funding for this research was provided by:
Joint Programming Initiative on Antimicrobial Resistance (01KI1824)
Bundesministerium für Bildung und Forschung (01KI213)
Deutsches Zentrum für Infektionsforschung (06.826)
Deutsche Forschungsgemeinschaft (390874280)
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 30 December 2024
First Online: 9 January 2025
Competing interests
: T.S., L.O., and M.W. filed a patent for the use of <i>K. oxytoca</i> to decolonize MDR Enterobacteriaceae from the gut (EP4259171A1, EP4011384A1, WO002022122825A1 & US020240041950A1). The remaining authors declare no competing interests.
